Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization

Liver

Volumn 19, Issue 1, 1999, Pages 25-31

  Kobayashi, Nao ^a   Ishii, Motoyasu ^a   Ueno, Yoshiyuki ^a   Kisara, Norihiro ^a   Chida, Nobuyuki ^a   Iwasaki, Takao ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anoxia; Bcl 2; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Vascular endothelial growth factor

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; VASCULOTROPIN;

ADULT; ANOXIA; APOPTOSIS; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CELL; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MORPHOMETRICS; PROTEIN EXPRESSION; PROTEIN INDUCTION;

CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; CHEMOEMBOLIZATION, THERAPEUTIC; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032923231     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00005.x     Document Type: Article

References (35)

1. BREEDIS C, YOUNG G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-77.
2. YAMADA R, SATO M, KAWABATA M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401.
3. MATSUI O, KADOYA M, YOSHIKAWA J, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188: 79-83.
4. OHNISHI K, YOSHIOKA H, KOSAKA K, et al. Treatment of hypervascular small hepatocellular carcinoma with ultrasound-guided percutaneous acetic acid injection: comparison with segmental transcatheter arterial embolization. Am J Gastroenterol 1996; 91: 2574-9.
5. ROSSER B G, GORES G J. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
6. STRASSER A, HARRIS A W, JACKS T, CORY S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994; 79: 329-39.
7. SARAFIAN T A, BREDESEN D E. Invited commentary is apoptosis mediated by reactive oxygen species? Free Radi Res 1994; 21: 1-8.
8. LIN J K, CHOU C K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Research 1992; 52: 385-8.
9. HINO N, HIGASHI T, NOUSO K, et al. Apoptosis and proliferation of human hepatocellular carcinoma. Liver 1996; 16: 123-9.
10. CULOTTA E, KOSHLAND D E, JR. p53 sweeps through cancer research. Science 1993; 262: 1958-61.
11. HSU I C, METCALF R A, SUN T, et al. Mutational hot-spot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-8.
12. BRESSAC B, KEW M, WANDS J, OZTURK M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-31.
13. HOCKENBERY D, NUNEZ G, MILLIMAN C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
14. YUNIS J J, MAYER M G, ARNESEN M A, et al. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med 1989; 320: 1047-54.
15. BUBENDORF L, SAUTER G, MOCH H, et al. Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol 1996; 148: 1557-65.
16. GROVER R, WILSON G D. Bcl-2 expression in malignant melanoma and its prognostic significance. Eur J Surg Oncol 1996; 22: 347-9.
17. ZHAO M, ZHANG N X, ECONOMOU M, et al. Immunohistochemical detection of Bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 1994; 25: 237-45.
18. MINCHENKO A, BAUER T, SALCEDA S, CARO J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 1994; 71: 374-9.
19. EDMONDSON H A, STEINER P E. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
20. SHI S R, KEY M E, KALRA K L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histcchem Cytochem 1991; 39: 741-8.
21. MISE M, ARII S, HIGASHITUJI H, et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996; 23: 455-64.
22. SHIMIZU S, EGUCHI Y, KOSAKA H, et al. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 1995; 374: 811-3.
23. ZHONG L T, SARAFIAN T, KANE D J, et al. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993; 90: 4533-7.
24. CHARLOTTE F, L'HERMINE A, MARTIN N, et al. Immunohistochemical detection of Bcl-2 protein in normal and pathological human liver. Am J Pathol 1994; 144: 460-5.
25. FERNANDEZ A, MARIN M S, MCDONNELL T, ANANTHASWAMY H N. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor : induction of Bcl -2, c-myc, and manganese superoxide dismutase in resistant cells. Oncogene 1994; 9: 2009-17.
26. LIU T, CLARK R K, MCDONNELL P C, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-8.
27. MIYASHITA T, KRAJEWSKI S, KRAJEWSKA M, et al. Tumor suppressor p53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-805.
28. VAUX D L, CORY S, ADAMS J M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-2.
29. GERLACH C, SAKKAB D Y, SCHOLZEN T, et al. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997; 26: 573-8.
30. YAO K S, XANTHOUDAKIS S, CURRAN T, O'DWYER P J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994; 14: 5997-6003.
31. COLLETTI L M, REMICK D G, BURTCH G D, et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-43.
32. HOCKENBERY D M, OLTVAI Z N, YIN X M, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51.
33. AYHAN A, YASUI W, YOKOZAKI H, et al. Loss of heterozygosity at the Bcl-2 gene locus and expression of Bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 1994; 85: 584-91.
34. ADACHI E, MATSUMATA T, NISHIZAKI T, et al. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993; 72: 3593-8.
35. GRAEBER T G, OSMANIAN C, JACKS T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996; 379: 88-91.